Nebido (Testosterone Undecanoate)

Testosterone undecanoate, the active ingredient in Nebido, is an androgen presented as a 1000 mg/4 mL intramuscular injection solution for intramuscular use. As a long‑acting ester prodrug, it is hydrolyzed after injection to release testosterone, treating male hypogonadism, providing testosterone replacement therapy, and addressing delayed puberty in males.

GNH USA supplies Nebido as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across the European Union and adherence to stringent quality and regulatory standards, and reliable logistics for timely delivery.

Nebido (testosterone undecanoate) acts on the androgen pathway to restore physiological testosterone levels in men with deficiency states.

Male hypogonadism: restores normal testosterone concentrations, improving energy, libido and muscle mass. Testosterone replacement therapy: alleviates symptoms of testosterone deficiency such as fatigue, loss of bone density and reduced sexual function. Delayed puberty in males: supports development of secondary sexual characteristics and growth.

Nebido may be associated with a range of adverse reactions following intramuscular administration.

Common Side Effects: - Injection site pain - Headache - Acne

Serious or Rare Side Effects: - Polycythemia leading to thrombosis - Cardiovascular events such as myocardial infarction or stroke - Severe allergic reactions including anaphylaxis

Prior to initiating Nebido, several safety considerations should be observed.

Monitor hematocrit: check blood counts regularly to detect polycythemia. Assess prostate health: evaluate for benign hypertrophy or cancer before initiating therapy. Evaluate cardiovascular risk: consider history of heart disease before treatment. Avoid use in known breast cancer: contraindicated due to androgenic stimulation. Use caution in liver disease: adjust monitoring if hepatic impairment present. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Nebido can interact with other medicines; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Insulin or oral hypoglycemics: altered glucose control, may require dose adjustment. - Strong CYP3A4 inhibitors (e.g., ketoconazole): raise testosterone levels, risk of adverse effects.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance blood pressure lowering effect. - Glucocorticoids: may suppress endogenous hormone axis, requiring monitoring. - Selective serotonin reuptake inhibitors (SSRIs): may affect libido, monitor patient response.